Clinical trial
Multicentre Observational, Prospective Cohort Study Including Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Who Receive Cangrelor i.v. Transitioning to Clopidogrel, Prasugrel or Ticagrelor Per os
NCT04471870 is registered in ClinicalTrials.gov with Chiesi Farmaceutici S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentre Observational, Prospective Cohort Study Including Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Who Receive Cangrelor i.v. Transitioning to Clopidogrel, Prasugrel or Ticagrelor Per os
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 23, 2020
- Completion date
- January 17, 2022
- Enrollment
- 1,005 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.